Global Neuroscience Insights Lead, Assets & Programs

Takeda Pharmaceutical Company Limited

Adams (MA)

Hybrid

USD 154,000 - 243,000

Full time

7 days ago

Be an early applicant

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

Takeda Pharmaceutical Company Limited in Cambridge, MA is seeking a Global Insights Lead for Neuroscience Assets & Programs to drive end-to-end research and competitive intelligence for its Neuroscience franchise. You will own project scoping, design, vendor management, synthesis, and delivery of decision-ready recommendations to inform clinical development and early commercial strategy.

The role partners with R&D, Medical, Commercial and regional teams to translate business questions into

Qualifications

8-10+ years of experience in market research, insights, forecasting, analytics, or strategy required.
Background in strategic consulting or competitive intelligence strongly preferred.
Experience supporting drug development and/or commercialization (launch or inline).
Experience contributing to patient-based forecasts, including developing and validating inputs and assumptions and tracking changes over time.
Demonstrated experience contributing to launch strategy or commercial readiness efforts.
Strong analytical, synthesis, and communication skills.

Responsibilities

Lead end-to-end qualitative and quantitative research for assigned assets/indications to understand treatment landscapes, unmet need, and treatment dynamics; manage project plans, vendors, timelines, and assigned research budgets within agreed approvals.
Monitor competitors, pipeline developments, and evolving standards of care for assigned programs; identify implications and elevate material risks or changes.
Integrate research and competitive intelligence into clear implications and recommendations for cross-functional teams.
Provide evidence-based recommendations to inform indication strategy, study design, endpoints, and positioning, in partnership with accountable clinical and commercial leaders.
Inform the Clinical Development Plan (CDP) and early commercial strategy with insight-driven perspectives.